V
ABMD

Veritable’s Abiomed Inc ABMD Stock Holding History

Veritable’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,143
Closed -$281K – 900
2022
Q3 		$281K Sell
1,143
-6
-0.5% -$1.62K 0.01% 651
2022
Q2 		$284K Buy
1,149
+95
+9% +$25.6K 0.01% 701
2022
Q1 		$349K Buy
1,054
+28
+3% +$8.62K 0.01% 663
2021
Q4 		$369K Sell
1,026
-23
-2% -$7.77K 0.01% 645
2021
Q3 		$341K Buy
1,049
+29
+3% +$9.82K 0.01% 650
2021
Q2 		$318K Buy
1,020
+8
+0.8% +$2.45K 0.01% 664
2021
Q1 		$323K Buy
+1,012
New +$324K 0.01% 635
2019
Q4 		– Sell
-1,349
Closed -$240K – 840
2019
Q3 		$240K Buy
1,349
+408
+43% +$88.2K ﹤0.01% 718
2019
Q2 		$245K Sell
941
-88
-9% -$23.3K ﹤0.01% 709
2019
Q1 		$294K Buy
+1,029
New +$342K 0.01% 654
2018
Q3 		– Sell
-673
Closed -$275K – 845
2018
Q2 		$275K Buy
+673
New +$244K 0.01% 670

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Veritable's ABMD Position: Q4 2022 in Review

Veritable sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,143 shares — an estimated $281K sold.

Veritable first reported a position in ABMD in Q2 2018 and held it in 11 quarters. The position peaked at $369K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Veritable reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Veritable sold 1,143 Abiomed Inc shares in Q4 2022, an estimated $281K.
  • Veritable first reported a position in Abiomed Inc in Q2 2018 and held it in 11 quarters.
  • Veritable's Abiomed Inc position peaked at $369K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Veritable's 13F filing for Q4 2022, filed 14 Feb 2023.